🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 372279109
- Market Cap
- Small Cap · $223 Million
- IPO
- 3/27/2019 · $20.32/share
- ADR Ratio
- 1:1
Business: Genfit S.A. is a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs, corresponding to a lack of approved treatments.
Company Contact
- CEO
- Pascal Prigent
- CFO
- Thomas Baetz
- Investor Relations
- Jean-Christophe Marcoux · 617-714-5252 · investors@genfit.com